카프노그래피 기기 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the capnography devices market size is expected to grow from USD 626.84 million in 2025 to USD 669.4 million in 2026 and is forecast to reach USD 929.58 million by 2031 at 6.79% CAGR over 2026-2031.

This report Segments the Industry Into by Product (Hand-Held, Stand-Alone), by Technology (Side Stream, Main Stream, Micro Stream), by Application (Critical Care, Sleep Studies, and More), by End-User (Hospitals, Ambulatory Surgical Centers, Other End-Users), and Geography. The Market Sizes and Forecasts are Provided in Terms of Value (USD).

Global Capnography Devices Market Trends and Insights

Rising Number of Surgeries Worldwide

Ambulatory surgical centers treated 3.3 million Medicare beneficiaries in 2024, underscoring a systemic shift toward outpatient care where reliable respiratory monitoring is indispensable . Enhanced recovery protocols and increasingly complex minimally invasive techniques demand real-time CO2 measurement to catch hypoventilation before oxygen saturation drops. As more specialties adopt moderate sedation outside the operating room, Capnography devices market adoption widens among gastroenterologists, cardiologists and pain-management teams. Purchasing decisions now prioritize monitors that are portable, battery-powered and Wi-Fi-enabled, allowing seamless use from pre-op to discharge bays. Vendors that bundle disposables under value contracts are gaining traction by lowering per-procedure costs in price-sensitive ambulatory settings.

Growing Prevalence of Respiratory Diseases

Chronic respiratory illnesses such as COPD and post-viral complications continue to rise, pushing healthcare providers to adopt continuous CO2 monitoring for early deterioration detection. Capnography has demonstrated higher sensitivity than pulse oximetry alone in identifying hypoventilation, which is driving protocols that combine both modalities in respiratory wards. Sleep labs increasingly deploy portable capnographs for home-based studies, supporting faster diagnosis and treatment initiation for obstructive sleep apnea. Public-health agencies warn of elevated readmission rates tied to undetected nocturnal hypoventilation, prompting insurers to reimburse capnography use in chronic-care bundles. These dynamics nurture sustained Capnography devices market expansion across in-patient and at-home environments.

Shortage of Skilled Respiratory & Anesthesia Technologists

Vacancy rates for respiratory therapists and anesthesia technologists surpassed 12% in 2024, a record high that slows new-device rollouts. Facilities without sufficient expertise struggle to interpret complex waveform anomalies, under-utilizing advanced functions and weakening the clinical value proposition. Vendors respond with auto-interpretation software and interactive tutorials to shorten learning curves, but onboarding still extends procurement cycles. Academic programs expand enrollment yet face faculty shortages, signalling that labor tightness will persist into the medium term. Consequently, some hospitals defer capnography upgrades until staffing stabilizes, tempering near-term Capnography devices market momentum.

Other drivers and restraints analyzed in the detailed report include:

1. Technological Advancements in Capnography
2. Strong Professional-Society Recommendations
3. High Capital & Disposable Costs of Capnography Systems

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

The Capnography devices market size for stand-alone systems accounted for USD 345.51 million in 2025, equivalent to 55.12% of total revenue. Hospitals value their full-screen displays, waveform storage and advanced alarm options that support critical-care workflows. However, hand-held devices are carving out a rapid 7.66% CAGR thanks to emergency medical services, transport teams and dental practices that require light, battery-powered units. In many regions, EMS protocols now treat capnography as a standard vital sign for intubated patients, propelling bulk purchases by ambulance fleets.

Demand for mobility also spurs hybrid cart-mounted solutions that dock hand-held modules when high-resolution analysis is needed. Manufacturers integrate Bluetooth and cellular modems so paramedics can stream waveforms to emergency departments for pre-arrival triage. As connectivity expands, software subscriptions become a rising share of product revenue, aligning vendor incentives with device uptime. This ecosystem approach positions portable platforms to capture incremental Capnography devices market share even while stand-alone consoles remain indispensable for intensive-care environments.

Side-stream analyzers retained the largest Capnography devices market share at 61.78% in 2025, favored for versatility and compatibility with existing monitors. Yet micro-stream units are growing at an 7.92% CAGR and are expected to narrow the gap by 2031. Their ultra-low sampling flow minimizes dead-space impact and improves accuracy in neonates, obese patients and those with low tidal volumes. Clinical studies reveal superior correlation between end-tidal CO2 and arterial PaCO2 across variable breathing patterns, reinforcing clinician confidence.

Operational efficiency is another selling point: closed water traps slash filter changes and reduce alarm fatigue from clogging. Lower disposables usage limits waste generation, an increasingly important procurement criterion under hospital sustainability mandates. As micro-stream sensors transition from proprietary to semi-standard connectors, price premiums are expected to compress, accelerating conversions. Main-stream technology will remain important in operating rooms that prefer airway-attached cuvettes to avoid sampling delays, but its share is likely to plateau over the forecast horizon.

Complete Report Scope:

• By Product
  • Hand-held
  • Stand-alone
• By Technology
  • Side-stream
  • Main-stream
  • Micro-stream
• By Application
  • Critical Care
  • Sleep Studies
  • Pain Management
  • Procedural Sedation
  • Other Applications
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America remained the largest regional contributor with 42.32% of 2025 revenue, buoyed by early clinician adoption, broad reimbursement and a strong supplier footprint. Federal alignment with ISO 13485 and swift 510(k) pathways shorten time-to-market for product enhancements, keeping domestic portfolios current. Strategic interoperability alliances, such as the 2024 Masimo-Philips integration that embedded NomoLine technology into multi-parameter monitors, give providers a simpler upgrade roadmap.

Europe delivers steady, replacement-driven growth anchored in stringent safety protocols. The European Commission's 2025 supply-chain transparency rules compel manufacturers to confirm continuity of capnography disposables, fostering resilient procurement frameworks. National health systems favor integrated monitors that consolidate capnography, oximetry and hemodynamics to minimize bedside clutter. Meanwhile, regional funding for digital health pilots accelerates adoption of cloud-connected capnographs in rural clinics.

Asia-Pacific represents the fastest-growing region with a 9.08% CAGR to 2031, propelled by rising surgical volumes, urban hospital construction and increasing chronic respiratory disease incidence. Government initiatives that subsidize ICU bed expansion in China and India indirectly galvanize Capnography devices market demand. Although country-specific regulatory timelines vary, the push for local manufacturing partnerships is reducing import tariffs and speeding deployments. Australia, Japan and South Korea continue as premium-technology markets where AI-enhanced waveform analysis commands early attention. Middle East & Africa and South America trail in adoption but show upticks where public-private partnerships bring modern critical-care infrastructure to tertiary centers.

1. Medtronic
2. Koninklijke Philips
3. Masimo
4. Dragerwerk
5. Nihon Kohden
6. Beckton Dickinson
7. Smiths Medical (Smiths Group)
8. Nonin Medical
9. SunMed
10. Infinium Medical
11. Welch Allyn (Hillrom / Baxter)
12. DiMedica
13. GE Healthcare
14. Zoll Medical
15. Hamilton Medical
16. Mindray
17. Teleflex
18. Capnomed
19. Qinhuangdao Kapunuomaite Medical
20. CapnoMedical (CapnoAcademy)

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Number Of Surgeries Worldwide
  • 4.2.2 Growing Prevalence Of Respiratory Diseases
  • 4.2.3 Technological Advancements In Capnography Devices
  • 4.2.4 Strong Professional-Society Recommendations
  • 4.2.5 Ai-Enabled Waveform Analytics For Early Sepsis Detection
  • 4.2.6 Integration Of Capnography Into Remote-Patient-Monitoring Wearables
• 4.3 Market Restraints
  • 4.3.1 Shortage Of Skilled Respiratory & Anesthesia Technologists
  • 4.3.2 High Capital & Disposable Costs Of Capnography Systems
  • 4.3.3 Slow Iso Revision On Microstream Disposables Delays Tenders
  • 4.3.4 Limited Neonatal Data On Ultra-Low-Flow Microstream Accuracy
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product
  • 5.1.1 Hand-held
  • 5.1.2 Stand-alone
• 5.2 By Technology
  • 5.2.1 Side-stream
  • 5.2.2 Main-stream
  • 5.2.3 Micro-stream
• 5.3 By Application
  • 5.3.1 Critical Care
  • 5.3.2 Sleep Studies
  • 5.3.3 Pain Management
  • 5.3.4 Procedural Sedation
  • 5.3.5 Other Applications
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Ambulatory Surgical Centers
  • 5.4.3 Other End-Users
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East & Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Overview, Market Overview, Core Segments, Financials, Strategic Info, Market Rank/Share, Products & Services, Recent Developments)
  • 6.3.1 Medtronic Plc
  • 6.3.2 Koninklijke Philips N.V.
  • 6.3.3 Masimo Corporation
  • 6.3.4 Dragerwerk AG & Co. KGaA
  • 6.3.5 Nihon Kohden Corporation
  • 6.3.6 Becton, Dickinson and Company
  • 6.3.7 Smiths Medical (Smiths Group)
  • 6.3.8 Nonin Medical, Inc.
  • 6.3.9 SunMed
  • 6.3.10 Infinium Medical, Inc.
  • 6.3.11 Welch Allyn (Hillrom / Baxter)
  • 6.3.12 DiMedica
  • 6.3.13 GE Healthcare
  • 6.3.14 Zoll Medical Corporation
  • 6.3.15 Hamilton Medical AG
  • 6.3.16 Shenzhen Mindray Bio-Medical Electronics
  • 6.3.17 Teleflex Inc.
  • 6.3.18 Capnomed
  • 6.3.19 Qinhuangdao Kapunuomaite Medical
  • 6.3.20 CapnoMedical (CapnoAcademy)

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment